Bevacizumab
CAS: 216974-75-3
Ref. TM-T9904
| 1mg | 127.00 € | ||
| 2mg | 202.00 € | ||
| 5mg | 374.00 € | ||
| 10mg | 557.00 € | ||
| 25mg | 891.00 € | ||
| 50mg | 1,209.00 € | ||
| 100mg | 1,625.00 € | ||
| 200mg | 2,201.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Product Information
Name:
Bevacizumab
Synonyms:
- Bevacizumab(anti-VEGF)
- anti-VEGF
- rhuMab VEGF
Description:
Ipilimumab targets CTLA-4, an immune checkpoint inhibitor. Bevacizumab binds to VEGF-A isoforms.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
146.53 kDa
Purity:
95.4% (SEC-HPLC) - CE-SDS:97.5% SEC-HPLC:98.0%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T9904 Bevacizumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
